Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.
about
Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of the chromogenic ...... tion in an outpatient setting.
@en
type
label
Evaluation of the chromogenic ...... tion in an outpatient setting.
@en
prefLabel
Evaluation of the chromogenic ...... tion in an outpatient setting.
@en
P2093
P2860
P1433
P1476
Evaluation of the chromogenic ...... tion in an outpatient setting.
@en
P2093
Betty Sanchez-Catanese
Brian Buckley
James P Luyendyk
Leonid Kagan
P2860
P2888
P356
10.1186/S12959-016-0084-2
P577
2016-05-06T00:00:00Z
P6179
1027945667